NSGO-FANDANGO/ENGOT-EN1 : a randomized phase II study of first-line combination chemotherapy with nintedanib/placebo in advanced/ recurrent endometrial cancer

Source
Gynecologic oncology - ISSN 0090-8258-199 (2025) p. 79-87
Author(s)
    Kristina Lindemann, Dominique Berton, Jalid Sehouli, Rene DePont Christensen, Sevilay Altintas, Anja Or Knudsen, Pierre-Etienne Heudel, Beyhan Ataseven, Ignace Vergote, Gabriel Lindahl, Coriolan Lebreton, Fabienne Schochter, Annika Auranen, Philippe Follana, Kristine Madsen, Frederic Selle, Karen Stampe Petersson, Florence Joly, Elena Ioana Braicu, Mansoor Raza Mirza